3 results
Not approvedWill not start
1.3. Study Design Rationale The ATLAS-INH trial (ALN-AT3SC-003) is a multicenter, multinational, randomized, openlabel Phase 3 study designed to demonstrate the efficacy and safety of fitusiran in patients with haemophilia A or B with inhibitory…
Approved WMOCompleted
Primary objective: Determine for different control algorithms and robotic modules whether the algorithm and/or robotic module is effective in providing the patient with the required support and measure bringing about the desired changes in the…
Approved WMOCompleted
Evaluation of the effect of daratumumab in combination with ATRA in patients with relapsed/refractory multiple myeloma